Matthew Shair, Director at Nuvalent, Inc. (NUVL), sold 75,000 shares at $64.52 ($4.8M) on 2024-04-22, disclosed to the SEC on 2024-04-24.
Scheduled sale ($4.8M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $62.66 | 14,156 | $887K | 18.6% |
| 2 | $62.66 | 14,156 | $887K | 18.6% |
| 3 | $63.80 | 8,694 | $555K | 11.6% |
| 4 | $63.80 | 8,694 | $555K | 11.6% |
| 5 | $64.52 | 14,650 | $945K | 19.8% |
| 6 | $64.52 | 14,650 |
| $945K |
| 19.8% |
| Total | $63.65 avg | 75,000 | $4.8M | 100% |
| Filing → |
| NUVL | SELL | 2025-02-25 | $265K | — | Filing → |
| NUVL | SELL | 2025-01-29 | $302K | — | Filing → |
| NUVL | SELL | 2024-12-26 | $285K | — | Filing → |